-
Loading metrics
Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
- Jeffrey R. Currier,
- Viseth Ngauy,
- Mark S. de Souza,
- Silvia Ratto-Kim,
- Josephine H. Cox,
- Victoria R. Polonis,
- Patricia Earl,
- Bernard Moss,
- Sheila Peel,
- Bonnie Slike
x
- Published: November 15, 2010
- https://doi.org/10.1371/journal.pone.0013983
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved